USANA Health Sciences Inc (USNA) KPIs and segments
Close on Nov 13, 2026Market cap $244.63MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive USANA Health Sciences's business
USANA Health Sciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Core Nutritional($M) | 192 | 204 | 199 | 211 | |||||||||
Direct selling($M) | 176 | 199 | 210 | 210 | 198 | 211 | 226 | 220 | 212 | ||||
Hiya($M) | 28.3 | 32.2 | 30.1 | 30.8 | 33.9 | 37.1 | |||||||
Other($M) | 6.05 | 7.00 | 2.79 | 2.00 | 1.68 | 1.75 | 1.66 | 1.65 | 1.48 | 1.43 | |||
Rise($M) | 3.41 | 13.7 | 2.43 | 1.63 | |||||||||
Asia Pacific total($M) | 157 | 169 | 151 | 139 | 163 | 173 | 167 | 160 | 171 | 185 | 177 | 170 | |
Greater China($M) | 115 | 123 | 100 | 92.6 | 113 | 119 | 113 | 102 | 116 | 128 | 116 | 107 | |
China($M) | 105 | 113 | 89.4 | 82.6 | 102 | 108 | 101 | 91.3 | 105 | 116 | 105 | 94.7 | |
Americas and Europe($M) | 66.1 | 80.9 | 75.1 | 74.2 | 72.6 | 76.1 | 46.4 | 40.2 | 42.2 | 42.7 | 44.0 | 43.4 | |
United States($M) | 49.1 | 63.5 | 56.0 | 56.9 | 54.1 | 57.9 | 26.5 | 21.5 | 21.6 | 22.2 | 23.3 | 23.0 | |
Southeast Asia Pacific($M) | 28.7 | 30.7 | 34.2 | 29.2 | 32.9 | 35.7 | 38.1 | 37.3 | 35.4 | 36.1 | 39.1 | 39.2 | |
South Korea($M) | 16.4 | 17.2 | 16.1 | 20.1 | 19.3 | 21.0 | 21.6 | 23.7 | |||||
North Asia($M) | 13.8 | 15.4 | 16.8 | 17.7 | 17.2 | 18.9 | 16.5 | 20.5 | 19.7 | 21.4 | 22.1 | 24.2 | |
Core Nutritional($M) | 12.8 | 18.2 | 13.3 | 16.9 | |||||||||
Direct selling($M) | 2.50 | 13.9 | 17.5 | 9.45 | 16.8 | 19.0 | 25.6 | ||||||
Rise($M) | -1.72 | -1.77 | -0.31 | -0.72 | |||||||||
Other($M) | -3.68 | -0.64 | -0.88 | -1.29 | -1.39 | -1.16 | -1.13 | -0.92 | |||||
Hiya($M) | -31.1 | -2.60 | 0.85 | -0.64 | 3.72 | -0.53 | |||||||
Core Nutritional($M) | 155 | 168 | 163 | 174 | |||||||||
Direct selling($M) | 143 | 163 | 173 | 173 | 160 | 172 | 184 | ||||||
Hiya($M) | 19.2 | 22.2 | 21.1 | 19.9 | 21.6 | 23.0 | |||||||
Other($M) | 0.92 | 2.26 | 1.19 | 0.84 | 0.82 | 0.78 | 0.77 | 0.85 | |||||
Rise($M) | 0.37 | 0.97 | 0.93 | 0.57 | |||||||||
Americas and Europe($M) | 472 | 475 | 333 | ||||||||||
Asia Pacific total($M) | 271 | 273 | 299 | ||||||||||
Greater China($M) | 195 | 202 | 220 | ||||||||||
Southeast Asia Pacific($M) | 50.8 | 44.8 | 57.8 | ||||||||||
North Asia($M) | 25.1 | 25.9 | 21.8 | ||||||||||
4 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?